Status:
UNKNOWN
Ovarian Hyperstimulation Syndrome Using Calcium Infusion
Lead Sponsor:
Al-Azhar University
Conditions:
Ovarian Hyperstimulation Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
the incidence of OHSS and clinical outcomes after calcium IV infusion in high-risk women undergoing ART
Detailed Description
Among assisted reproductive technologies (ART), ovarian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication affects up to 30% of women undergoing ART and caries high risks of morbidi...
Eligibility Criteria
Inclusion
- \- infertile women aged 20 to 38 years. BMI ranged from 18 to 40. serum FSH within normal limits( 1-12IU /l) presented with ovarian response suggestive of being at risk of developing OHSS because of the presence of at least 15 follicles of 10 mm or greater on the day of hCG administration.
Exclusion
- endocrinopathies. a systemic disease. and Insulin-dependent diabetes Thyroid disease using any medication (e.g., insulin-sensitizing drugs and GnRH antagonists. patients need coasting for high risk of OHSS. patients need cycle cancellation. severe male infertility requiring testicular sperm extraction.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 10 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05198128
Start Date
March 1 2022
End Date
May 10 2023
Last Update
February 22 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.